Pfizer's Inlyta drug misses kidney-cancer endpoint; Sanofi wants to turn closed factory into IT hub;

@FiercePharma: Our latest ranking: 10 Largest Settlements and Judgments. Includes those big state deals. More | Follow @FiercePharma

> Pfizer's ($PFE) cancer drug Inlyta fell short in a study in kidney cancer patients, but company officials said it was close, and sub-populations may merit further study. Report

> Sanofi ($SNY) is trying to recruit high-tech companies to develop an IT hub on the site of its factory in Dagenham, England, which is slated for closure as part of a global cost-cutting effort. Report

> Federal prosecutors raided New England Compounding Center, the pharmacy tied to a meningitis outbreak. Report

> Novo Nordisk ($NVO) has contributed more money to U.S. candidates this election cycle--about $176,000--than any other contributor from Denmark. Report

> Richard Roberts, CEO of URL Pharmaceuticals until it was sold to Takeda in June, funded a new political group to support Florida Rep. Allen West; he contributed $1 million to the effort. Report

> The European Union's health commissioner stepped down amid corruption charges related to tobacco products. Report

Biotech News

 @FierceBiotech: Scientists produced stem cells from cadaver scalp tissue. Item | Follow @FierceBiotech

 @JohnCFierce: Looks like Samsung is getting a taste of just how devilishly hard it can be to develop drugs. More | Follow @JohnCFierce

 @RyanMFierce: Charles River is touting a 3-year strategic deal with AstraZeneca, which is outsourcing across the globe. More | Follow @RyanMFierce

> Cebix gains $31M, new CEO as it preps for PhIIb diabetes study. Story

> FDA advisers back NPS Pharma's orphan bowel drug. Article

Medical Device News

 @FierceMedDev: The FDA has slapped its most serious label on Accutron's voluntary flowmeter recall. More | Follow @FierceMedDev

 @MarkHFierce: New device company Cibiem launches with $10M series A. More | Follow @MarkHFierce

 @DamianFierce: AstraZeneca's inked a deal with another CRO, picking Charles River to help speed along its pipeline. More | Follow @DamianFierce

> Quest lowers outlook after Q3 profit drop. Story

> For some, Intuitive Surgical's Q3 20% revenue jump isn't enough. Article

> Analyst: China is primed for a medical device boom. News

Biomarkers News

> Gene variants increase bipolar risk. Article

> Protein marker could cut cost of cancer screening. More

> Gene variant in donated kidneys could mark survival. Report

> Endocyte uses vitamin receptor to tag lung cancer. Story

Drug Delivery News

> Simple anti-HIV vaginal ring delivers three months of protection. Story

> Over the moon? NASA develops motion sickness nasal spray. Item

> Why shape matters in gene delivery. More

> Hiding in plain sight: Using red blood cell proteins to deliver drugs. Article

> Unilife announces new eye delivery platforms. News

And Finally... FDA warned Avon Products about claims made on certain antiwrinkle products, a month after going after L'Oréal's Lancôme unit for similar reasons. Report